Increased sensitivity of the Roche COBAS AMPLICOR HCV test, version 2.0 using modified extraction techniques

Journal of Molecular Diagnostics

Volumn 6, Issue 3, 2004, Pages 225-230

  Forman, Michael Stuart ^a   Valsamakis, Alexandra ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DETERGENT; VIRUS RNA;

ARTICLE; BIOASSAY; BLOOD SAMPLING; CENTRIFUGATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC ACCURACY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; MEDICAL ASSESSMENT; RNA EXTRACTION; SENSITIVITY AND SPECIFICITY; VIRUS DETECTION;

HEPATITIS C VIRUS; STAPHYLOCOCCUS PHAGE 3A;

EID: 4344700663     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-1578(10)60514-4     Document Type: Article

References (16)

1. Lee SC, Antony A, Lee N, Leibow J, Yang JQ, Soviero S, Gutekunst K, Rosenstraus M: Improved version 2.0 qualitative and quantitative AMPLICOR reverse transcription-PCR tests for hepatitis C virus RNA: calibration to international units, enhanced genotype reactivity, and performance characteristics. J Clin Microbiol 2000, 38:4171-4179
2. Nolte FS, Fried MW, Shiffman ML, Ferreira-Gonzalez A, Garrett CT, Schiff ER, Polyak SJ, Gretch DR: Prospective multicenter clinical evaluation of AMPLICOR and COBAS AMPLICOR hepatitis C virus tests. J Clin Microbiol 2001, 39:4005-4012
3. Albadalejo J, Alonso R, Antinozzi R, Bogard M, Bourgault AM, Colucci G, Fenner T, Petersen H, Sala E, Vincelette J, Young C: Multicenter evaluation of the COBAS AMPLICOR HCV assay, an integrated PCR system for rapid detection of hepatitis C virus RNA in the diagnostic laboratory. J Clin Microbiol 1998, 36:862-865
4. Castro FJ, Sauleda S, Esteban JI, Viladomiu L, Martell M, Dragon E, Esteban R, Guardia J: Evaluation of hepatitis C virus RNA RT/PCR qualitative and quantitative second generation assays. J Virol Methods 2001, 91:51-58
5. Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Goncales Jr FL, Haussinger D, Diago M, Carosi G, Dhumeaux D, Craxi A, Lin A, Hoffman J, Yu J: Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347:975-982
6. McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK: Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C: Hepatitis Interventional Therapy Group. N Engl J Med 1998, 339:1485-1492
7. Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK: Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001, 358:958-965
8. Sarrazin C, Hendricks DA, Sedarati F, Zeuzem S: Assessment, by transcription-mediated amplification, of virologic response in patients with chronic hepatitis C virus treated with peginterferon alpha-2a. J Clin Microbiol 2001, 39:2850-2855
9. Beld M, Penning M, van Putten M, van den Hoek A, Damen M, Klein MR, Goudsmit J: Low levels of hepatitis C virus RNA in serum, plasma, and peripheral blood mononuclear cells of injecting drug users during long antibody-undetectable periods before seroconversion. Blood 1999, 94:1183-1191
10. Piwowar-Manning EM, Henderson TA, Brisbin L, Jackson JB: A modified ultrasensitive assay to detect quantified HIV-1 RNA of fewer than 50 copies per milliliter. Am J Clin Pathol 2003, 120:268-270
11. McHutchison JG, Blatt LM, Ponnudurai R, Goodarzi K, Russell J, Conrad A: Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection. J Med Virol 1999, 57:351-355
12. Schmidt WN, Klinzman D, LaBrecque DR, Macfarlane DE, Stapleton JT: Direct detection of hepatitis C virus (HCV) RNA from whole blood, and comparison with HCV RNA in plasma and peripheral blood mononuclear cells. J Med Virol 1995, 47:153-160
13. Stapleton JT, Klinzman D, Schmidt WN, Pfaller MA, Wu P, LaBrecque DR, Han J, Phillips MJ, Woolson R, Alden B: Prospective comparison of whole-blood- and plasma-based hepatitis C virus RNA detection systems: improved detection using whole blood as the source of viral RNA. J Clin Microbiol 1999, 37:484-489
14. Cook L, Ross AM, Knight GB, Agnello V: Use of whole blood specimens for routine clinical quantitation of hepatitis C virus RNA does not increase assay sensitivity. J Clin Microbiol 2000, 38:4326-4331
15. Hendricks DA, Friesenhahn M, Tanimoto L, Goergen B, Dodge D, Comanor L: Multicenter evaluation of the VERSANT HCV RNA qualitative assay for detection of hepatitis C virus RNA. J Clin Microbiol 2003, 41:651-656
16. Krajden M, Ziermann R, Khan A, Mak A, Leung K, Hendricks D, Comanor L: Qualitative detection of hepatitis C virus RNA: comparison of analytical sensitivity, clinical performance, and workflow of the Cobas Amplicor HCV test version 2.0 and the HCV RNA transcription-mediated amplification qualitative assay. J Clin Microbiol 2002, 40: 2903-2907